Chi­na work­ing on con­ces­sions to help home­grown com­pa­nies stay on US ex­changes — re­port

As the threat of delist­ing rat­tles a num­ber of US-list­ed Chi­nese com­pa­nies — in­clud­ing some promi­nent drug­mak­ers — Chi­na is re­port­ed­ly con­sid­er­ing some con­ces­sions to make things …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.